Drug companies have been required since 1 January to record any payments to doctors with a view to this becoming publicly searchable knowledge from July 2016. Writing in NLJ this week, Leigh Day solicitor Sarah Moore says the new code aims to encourage transparency, but she questions how successful the initiative will be. Doctors can formally opt out, she notes, while neither private hospitals nor medical device companies are covered by the requirement. Most crucially, she says, the code is voluntary.
13 February 2015
Medical transparency?
MOVERS & SHAKERS
Anthony Collins—William Hallett & Lorna Scully
Anthony Collins hires two talented legal directors
Switalskis—five appointments
Firm expands national abuse compensation team
Mathys & Squire—nine promotions
IP firm announces new partners and senior promotions across UK offices
NEWS
Executors may be overlooking billions of pounds in estate assets hidden in forgotten investments and misplaced share certificates
Britain’s booming non-surgical cosmetics market is operating in what some critics describe as a regulatory ‘Wild West’
Family contact disputes are becoming an increasingly prominent feature of Court of Protection litigation
Material obtained through US discovery applications may have a much longer legal life than many litigants realise
English courts are developing a distinctly practical approach to sanctions disputes arising from Russia’s invasion of Ukraine
Copyright © 2026 LexisNexis
